The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
about
The breast cancer epidemic: 10 factsTiming and duration of menopausal hormone treatment may affect cardiovascular outcomesDoes sexual dimorphism in human faces signal health?Progesterone receptors--animal models and cell signalling in breast cancer. Implications for breast cancer of inclusion of progestins in hormone replacement therapiesIdentifying patient preferences for communicating risk estimates: a descriptive pilot studyMenopausal hormone therapy after breast cancerThe Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the RiskResults of observational studies: analysis of findings from the Nurses' Health StudyMenopausal hormone therapy and breast cancer mortality: clinical implicationsPrescribing menopausal hormone therapy: an evidence-based approachA prospective study of postmenopausal hormone use and ovarian cancer riskLong-term cancer risk in women given diethylstilbestrol (DES) during pregnancyReproductive and hormonal risk factors of breast cancer: a historical perspective.Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancerValidation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study.Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008IMS reaction to recent breast cancer data.A chronology of the study of older women's health: data, discoveries, and future directions.Translesion synthesis past equine estrogen-derived 2'-deoxyadenosine DNA adducts by human DNA polymerases eta and kappa.Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.Disparities in mammographic screening for Asian women in California: a cross-sectional analysis to identify meaningful groups for targeted intervention.Balance of beneficial and deleterious health effects of quinones: a case study of the chemical properties of genistein and estrone quinones.Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial.The genetic basis of breast cancer and its clinical implications.Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis.Mammographic screening and risk factors for breast cancerCurrent and potential future drug treatments for osteoporosis.Selective estrogen receptor modulator delivery of quinone warheads to DNA triggering apoptosis in breast cancer cells.Phyto-oestrogens: a potential role in the prevention of CHD?Benefits and risks of hormone replacement therapy in young adult cancer survivors with gonadal failure.Raloxifene, a new selective estrogen receptor modulator.Why do women doctors in the UK take hormone replacement therapy?Estrogen action: a historic perspective on the implications of considering alternative approaches.Equine estrogen-induced mammary tumors in rats.Effect of SERMs on breast tissue.The role of SERMs in the management of postmenopausal osteoporosis.Concurrent Use in Taiwan of Chinese Herbal Medicine Therapies among Hormone Users Aged 55 Years to 79 Years and Its Association with Breast Cancer Risk: A Population-Based Study.Tamoxifen prevention of breast cancer: an instance of the fingerpost.Ethnic differences in hormone replacement prescribing patternsWhat is newsworthy? Bad news from research really is headline news.
P2860
Q22299214-78738FA3-2EB7-47E5-A6EC-5834384D1372Q24626206-67EE1EEF-9E6F-450E-AE1F-426D8150DC55Q24673142-EE7D30C6-8C87-47D4-B76F-87F7253E3C38Q24800282-B515C7F2-12B3-426D-BB45-0C3E585E627CQ24804138-910CBDEF-B3E0-4A39-856A-A2D08499B322Q24810837-A8730DBD-C161-45DD-BF11-EA83D2A26EAFQ26821782-9B8381BC-0A71-4D22-BE47-E8AAA6994F65Q27006022-F14BE77F-F869-498F-AF70-7E4A9DBF526EQ27022201-3EFEBD82-A1FF-4810-8303-69311EDAA51AQ27022920-CB6C24FA-1759-43B9-A285-DEC619E84025Q28213056-AB55E801-C91F-442B-976F-C17480FD0515Q28345491-96A18856-5F8C-4A8A-B968-6FFE231DBAC4Q30234506-B20964F3-5772-4E22-8987-C69EE1EF76B1Q30498819-2A56D965-DA0F-41D9-AC57-B28F5DB6324FQ30683824-213E4EB3-9F06-473D-8D03-7C0F97F1BB2DQ31036814-8205F683-A49A-4680-AD9C-B286219E1F87Q31105720-AC06313D-840E-4DFB-BA04-B0E8901C3AA7Q31872317-BEED0AB0-6950-403B-82D9-A96C28E9A3DFQ33242690-2D767B0E-EC7F-4C5D-999C-C393FC49056FQ33282313-D652DC7E-7C5D-42AF-86D0-B97003294B80Q33303945-B05D7889-5098-47FA-8208-BF50A0DD3591Q33396534-4BF8059C-28AB-4C4F-AA1B-78D862FFE006Q33503980-25E509C3-B02C-40B2-8535-57783E8ECDCBQ33536033-20FFAFCD-CBCF-41A4-BF8D-A2383A5D720BQ33566322-202AF0B2-B240-4421-B8AC-6A8902452E51Q33566626-7918A0E7-1E42-429C-A84A-02EEF9FD79E4Q33579316-A143804D-071D-4FD4-A335-42386F1407A1Q33622549-7B534AA3-B00D-484D-962D-A2053485B499Q33644539-D3100E8D-BEAB-43BD-87D4-A536E7CD76F1Q33684739-D9476680-94A5-4D3E-AED0-268A69093097Q33703846-D8A9E16E-93CF-4B49-9859-17E754AEFB69Q33704462-1D4E11D7-E1E2-4449-83F2-31BBEBFA0D3BQ33709986-241241D3-46FC-408D-8A4B-A5D99C3AFB76Q33721841-D539F363-9465-4263-BEBD-85DCD8CB017BQ33757750-7BDD6A11-5F58-4D49-AA1D-99367202786CQ33757760-DD19BB3D-0459-4706-9FE1-1D9EFE40EF1DQ33760016-35A8055C-1129-42CD-A15C-94D64B42FB57Q33765698-8EB61DB5-A4E4-499A-B391-8970755E7CCAQ33778878-AE62E28D-05BD-474B-A12B-2B64DF34A03BQ33812243-70A7A58C-A6F3-417D-ADB4-D5444ADD88A7
P2860
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
description
im Juni 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 June 1995
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 1995
@uk
name
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
@en
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
@nl
type
label
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
@en
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
@nl
prefLabel
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
@en
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
@nl
P2093
P1476
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
@en
P2093
Hankinson SE
Hennekens C
Speizer FE
Stampfer MJ
Willett WC
P304
P356
10.1056/NEJM199506153322401
P407
P577
1995-06-01T00:00:00Z